Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Suzhou Chunqiu Electronic Technology (603890.SH) shareholders plan to reduce their holdings by no more than 0.74% of the shares.

Shanghai Yct Electronics Group (301099.SZ) intends to launch a restricted stock incentive plan in 2025.

Aim to pacify market sentiment? Takamitsu Manana self-proclaimed: Japan will achieve its first basic fiscal surplus in 28 years by fiscal year 2026.
Suzhou Chunqiu Electronic Technology (603890.SH) shareholders plan to reduce their holdings by no more than 0.74% of the shares.

Shanghai Yct Electronics Group (301099.SZ) intends to launch a restricted stock incentive plan in 2025.

Aim to pacify market sentiment? Takamitsu Manana self-proclaimed: Japan will achieve its first basic fiscal surplus in 28 years by fiscal year 2026.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


